443 related articles for article (PubMed ID: 35817651)
1. Proteasome substrate receptors and their therapeutic potential.
Osei-Amponsa V; Walters KJ
Trends Biochem Sci; 2022 Nov; 47(11):950-964. PubMed ID: 35817651
[TBL] [Abstract][Full Text] [Related]
2. Role of E3 ubiquitin ligases and deubiquitinating enzymes in SARS-CoV-2 infection.
Zhao M; Zhang M; Yang Z; Zhou Z; Huang J; Zhao B
Front Cell Infect Microbiol; 2023; 13():1217383. PubMed ID: 37360529
[TBL] [Abstract][Full Text] [Related]
3. Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system.
Poirson J; Biquand E; Straub ML; Cassonnet P; Nominé Y; Jones L; van der Werf S; Travé G; Zanier K; Jacob Y; Demeret C; Masson M
FEBS J; 2017 Oct; 284(19):3171-3201. PubMed ID: 28786561
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitination and deubiquitination: Implications on cancer therapy.
Dagar G; Kumar R; Yadav KK; Singh M; Pandita TK
Biochim Biophys Acta Gene Regul Mech; 2023 Dec; 1866(4):194979. PubMed ID: 37633647
[TBL] [Abstract][Full Text] [Related]
5. Cryo-EM Reveals Unanchored M1-Ubiquitin Chain Binding at hRpn11 of the 26S Proteasome.
Chen X; Dorris Z; Shi D; Huang RK; Khant H; Fox T; de Val N; Williams D; Zhang P; Walters KJ
Structure; 2020 Nov; 28(11):1206-1217.e4. PubMed ID: 32783951
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin-proteasome system (UPS) as a target for anticancer treatment.
Park J; Cho J; Song EJ
Arch Pharm Res; 2020 Nov; 43(11):1144-1161. PubMed ID: 33165832
[TBL] [Abstract][Full Text] [Related]
7. Chemically Induced Cellular Proteolysis: An Emerging Therapeutic Strategy for Undruggable Targets.
Moon S; Lee BH
Mol Cells; 2018 Nov; 41(11):933-942. PubMed ID: 30486612
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin proteasome system in immune regulation and therapeutics.
Bhat SA; Vasi Z; Adhikari R; Gudur A; Ali A; Jiang L; Ferguson R; Liang D; Kuchay S
Curr Opin Pharmacol; 2022 Dec; 67():102310. PubMed ID: 36288660
[TBL] [Abstract][Full Text] [Related]
9. The emerging role of Deubiquitinases (DUBs) in parasites: A foresight review.
Kumar P; Kumar P; Mandal D; Velayutham R
Front Cell Infect Microbiol; 2022; 12():985178. PubMed ID: 36237424
[TBL] [Abstract][Full Text] [Related]
10. Hidden targets of ubiquitin proteasome system: To prevent diabetic nephropathy.
Goru SK; Kadakol A; Gaikwad AB
Pharmacol Res; 2017 Jun; 120():170-179. PubMed ID: 28363724
[TBL] [Abstract][Full Text] [Related]
11. Homo-PROTACs: bivalent small-molecule dimerizers of the VHL E3 ubiquitin ligase to induce self-degradation.
Maniaci C; Hughes SJ; Testa A; Chen W; Lamont DJ; Rocha S; Alessi DR; Romeo R; Ciulli A
Nat Commun; 2017 Oct; 8(1):830. PubMed ID: 29018234
[TBL] [Abstract][Full Text] [Related]
12. Deubiquitinating enzymes and the proteasome regulate preferential sets of ubiquitin substrates.
Trulsson F; Akimov V; Robu M; van Overbeek N; Berrocal DAP; Shah RG; Cox J; Shah GM; Blagoev B; Vertegaal ACO
Nat Commun; 2022 May; 13(1):2736. PubMed ID: 35585066
[TBL] [Abstract][Full Text] [Related]
13. Deubiquitinating enzyme inhibitors and their potential in cancer therapy.
Crosas B
Curr Cancer Drug Targets; 2014; 14(6):506-16. PubMed ID: 25088039
[TBL] [Abstract][Full Text] [Related]
14. A patent review of the ubiquitin ligase system: 2015-2018.
Li X; Elmira E; Rohondia S; Wang J; Liu J; Dou QP
Expert Opin Ther Pat; 2018 Dec; 28(12):919-937. PubMed ID: 30449221
[TBL] [Abstract][Full Text] [Related]
15. Role of the ubiquitin proteasome system in hematologic malignancies.
Sahasrabuddhe AA; Elenitoba-Johnson KS
Immunol Rev; 2015 Jan; 263(1):224-39. PubMed ID: 25510280
[TBL] [Abstract][Full Text] [Related]
16. Breaking the chains: deubiquitylating enzyme specificity begets function.
Clague MJ; Urbé S; Komander D
Nat Rev Mol Cell Biol; 2019 Jun; 20(6):338-352. PubMed ID: 30733604
[TBL] [Abstract][Full Text] [Related]
17. Timer-based proteomic profiling of the ubiquitin-proteasome system reveals a substrate receptor of the GID ubiquitin ligase.
Kong KE; Fischer B; Meurer M; Kats I; Li Z; Rühle F; Barry JD; Kirrmaier D; Chevyreva V; San Luis BJ; Costanzo M; Huber W; Andrews BJ; Boone C; Knop M; Khmelinskii A
Mol Cell; 2021 Jun; 81(11):2460-2476.e11. PubMed ID: 33974913
[TBL] [Abstract][Full Text] [Related]
18. Insights into a functional model of key deubiquitinases UBP12/13 in plants.
Zhang S; Hu N; Yu F
New Phytol; 2024 Apr; 242(2):424-430. PubMed ID: 38406992
[TBL] [Abstract][Full Text] [Related]
19. Proteasome-associated deubiquitinases and cancer.
Mofers A; Pellegrini P; Linder S; D'Arcy P
Cancer Metastasis Rev; 2017 Dec; 36(4):635-653. PubMed ID: 29134486
[TBL] [Abstract][Full Text] [Related]
20. Design Principles Involving Protein Disorder Facilitate Specific Substrate Selection and Degradation by the Ubiquitin-Proteasome System.
Guharoy M; Bhowmick P; Tompa P
J Biol Chem; 2016 Mar; 291(13):6723-31. PubMed ID: 26851277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]